COMPOSITIONS AND METHODS FOR TREATING PURPURA

摘要

Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an alpha adrenergic receptor agonist selected from selective alpha1 adrenergic receptor agonist, selective alpha2 adrenergic receptor agonist, non-selective alpha1/alpha2 adrenergic receptor agonist, agents with alpha2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.